Showing results (161-170 of 362) with videos related to

Sort By:
Pageof 37
Leukemia|April 7, 1998
Bolus vincristine and epirubicin with cyclophosphamide and dexamethasone (VECD) as induction and salvage treatment in multiple myelomaA Fosså, M Muer, C Kasper, et al.
Leukemia Research|September 1, 1992
No correlation between site of breakpoint in the BCR gene and platelet counts in Philadelphia chromosome-positive CMLB Opalka, U B Wandl, O Kloke, et al.
Cancer Genetics and Cytogenetics|July 2, 1998
Frequency of clonal B lymphocytes in chronic myelogenous leukemia evaluated by fluorescence in situ hybridizationA al-Amin, K Lennartz, V Runde, et al.
European Journal of Haematology|September 13, 2001
Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbonesM Jansen, W Bardenheuer, U R Sorg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalitiesM Sarbia, M Stahl, U Fink, et al.
Cancer Research|February 1, 1988
Spontaneous sister chromatid exchange in normal bone marrow and Ph-positive chronic myelocytic leukemiaR Becher, G Zimmer, G Prescher, et al.
Cancer Treatment Reports|October 1, 1986
Enhancement of semustine-induced cytotoxicity by chlorpromazine and caffeine in a human melanoma xenograftR Osieka, P Glatte, R Pannenbäcker, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft systemR Osieka, P Glatte, R Pannenbäcker, et al.
Strahlentherapie|October 1, 1982
[Enhancement of MeCCNU potency (chemosensitization) by misonidazole in a human melanoma xenograft system]R Osieka, P Glatte, U Haedecke, et al.
Onkologie|February 1, 1991
Anti-depressants and anti-convulsants for the treatment of neuropathic pain syndromes in cancer patientsM Kloke, K Höffken, H Olbrich, et al.
Pageof 37